FDA issues recall for blood pressure medication due to cancer risk

UTC
US NEWS FEEDS > OHIO >

The U.S. Food and Drug Administration has issued a recall for several drugs used to treat high blood pressure and heart failure due to the risk of cancer.The voluntary recall includes drugs containing the active ingredient valsartan.There has been an impurity found in valsartan called N-nitrosodimethylamine (NDMA). NDMA is classified as a probable human carcinogen based on lab tests.The following are products listed in the recall, according to the FDA:Valsartan from Major PharmaceuticalsValsartan from Solco HealthcareValsartan from Teva Pharmaceuticals Industries Ltd.Valsartan/Hydrochlorothiazide (HCTZ) from Solco HealthcareValsartan/Hydrochlorothiazide (HCTZ) from Teva Pharmaceuticals Industries Ltd.Patients who are taking one of the recalled...

READ MORE >
FDA issues recall for blood pressure medication due to cancer risk

Sponsored Content